Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease

Summary

GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonist which is being developed for once daily treatment of chronic obstructive pulmonary disease (COPD). The long duration of action of GSK233705 when administered via inhalation in animal models supports the potential for use as a once-daily bronchodilator for chronic obstructive pulmonary disease.

Timeline

Start

2006-08-16

Primary completion

—

Completion

2007-04-03

Drugs

Indications